AstraZeneca has agreed to purchase California-based respiratory medication developer, Pearl Therapeutics, in a deal with a total potential cost of up to $1.15bn. As per the definitive agreement signed between both the parties, AstraZeneca ...
Tags: AstraZeneca, Pearl Therapeutics
AstraZeneca Neuroscience Innovative Medicines (AZ NS iMed) has partnered with clinical services and eClinical solutions provider ePharmaSolutions to optimize clinical trial management technology. iMed will leverage IT solutions to share ...
The USFDA has granted priority review designation for investigational agent Metreleptin, jointly developed by Bristol-Myers Squibb Company and AstraZeneca, for the treatment of metabolic disorders associated with rare forms of ...
Leading global biopharmaceutical firm AstraZeneca has suspended expansion in the Chinese generic drug market. It announced adjustments on strategy for business in the Chinese mainland days ago and according to the adjustments, it will ...
Tags: Generic Drug Market, Health, Medicine
AstraZeneca has agreed to acquire Omthera Pharmaceuticals along with novel dyslipidemia treatment in a deal, which has a total potential cost of nearly $443m. As per the deal, AstraZeneca will acquire Omthera for $12.70 per share, or ...
Tags: Pharmaceuticals, Astrazeneca
Pharmaceutical company AstraZeneca Australia is investing an additional $20.2 million into its Sydney manufacturing operation to boost production of one of its key asthma medications in response to growing demand for the medicine from ...
Tags: Boost, AstraZeneca, medicine
Impax Laboratories has introduced authorized generic of Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5mg and 5mg, in the US. Global Pharmaceuticals, the generics division of Impax, commenced product shipment, as part ...
Tags: Impax Introduces, Generic of Zomig
UK-based drug discovery and development company Redx Pharma is planning to open a new £10.5m research and development facility at AstraZeneca's Alderley Park site in Cheshire, England. The new venture, Redx Anti-Infectives, will ...
Tags: Redx Pharma, Medicine
Ethicon Endo-Surgery's division Sedasys has received premarket approval (PMA) from the US Food and Drug Administration (FDA) for the first computer-assisted personalized sedation (CAPS) solution, Sedasys System. The system is used for the ...
Tags: Ethicon, Premarket Approval
Big data is not yet being embraced, according to Adrian Asher, chief information security officer (CISO) of the Skype division at Microsoft. Asher told delegates at Infosecurity Europe 2013 that big data is currently just a buzzword used ...
Tags: Big Data, Computer Products
Clinigen has acquired Cardioxane (dexrazoxane) from Novartis for $33m, which is payable in two tranches. As per the agreement, Clinigen will manufacture, register, distribute, and commercialize the product in countries where current ...
Tags: Clinigen, Cardioxane, Medicine
The United States District Court for the District of New Jersey has ruled that AstraZeneca's US patent protecting Pulmicort Respules in the US, is invalid. The Court also said that the generic defendants involved in the litigation do not ...
Tags: Pulmicort, Health, Pulmicort Patent
IT leaders at Computing's Big Data Summit 2013 yesterday agreed that social media analysis could benefit them internally as well as externally, and could be the next step for them in order to get the most out of their big data tools. Tony ...
Tags: Computer Products
There are opportunities for big data in cyber security, according to technology specialist at BSkyB Jamie Randall. Speaking at Computing's Big Data Summit 2013 today, Randall said that big data could be used to interpret alerts and ...
Tags: Computer Products, software
Companies are rebranding what they have offered for many years as "big data solutions", Financial Times CIO Christina Scott warned delegates at Computing's Big Data Summit today. Speaking at Computing's flagship event on the topic ...
Tags: Computer Products, software